[Breast cancer: radiotherapy and estrogen signaling] - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Bulletin du Cancer Année : 2014

[Breast cancer: radiotherapy and estrogen signaling]

Résumé

Hormone receptors are expressed in more than 75% of breast cancer. Therefore, two prescription modalities of endocrine therapy could be proposed: either sequential or concomitant to breast cancer irradiation. If combined to radiotherapy, is endocrine therapy a radiosensitizer? Does endocrine therapy enhance the risk factor of radio-induced toxicity? Here, we will distinguish the interaction of ionizing radiation combined with therapies targeting oestrogen receptor (REalpha) from the interaction of ionizing radiation with oestrogen. This review aims at making clear all these items.
Fichier non déposé

Dates et versions

hal-02168049 , version 1 (28-06-2019)

Identifiants

Citer

Céline Bourgier, Claire Lemanski, Gilles Romieu, M. Ozsahin, David Azria. [Breast cancer: radiotherapy and estrogen signaling]. Bulletin du Cancer, 2014, 101, pp.714--7. ⟨10.1684/bdc.2014.1954⟩. ⟨hal-02168049⟩
25 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More